New Edge Advisors, LLC Bio N Tech Se Transaction History
New Edge Advisors, LLC
- $18.3 Billion
- Q2 2025
A detailed history of New Edge Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, New Edge Advisors, LLC holds 6,525 shares of BNTX stock, worth $665,941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,525
Previous 1,835
255.59%
Holding current value
$665,941
Previous $167,000
315.57%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BNTX
# of Institutions
321Shares Held
40.9MCall Options Held
1.38MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$820 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$432 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$408 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$367 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$193 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...